From Eleven Bio Buys Viventia, Rebrands as Cancer Drug Developer:

Merger puzzle piece stock photo

Merger puzzle piece stock photo—

Photo credit: Depositphotos

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy Insight · Special Report
Biotech Startups: How to Succeed in a COVID-19 World
Industry experts explain what it takes to launch a new biotech company

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!